Patient characteristics
| Characteristic . | Patients . |
|---|---|
| Sex, male/female, no. (%) | 32/23 (58/42) |
| Age at SCT, y, median (range) | 44 (17-66) |
| Diagnoses, no | |
| ALL | 3 |
| AML | 11 |
| CIMF | 1 |
| CML | 2 |
| MDS | 5 |
| B-CLL | 1 |
| NHL | 9 |
| HD | 1 |
| MM | 21 |
| PNH | 1 |
| Donor, no. (%) | |
| Matched related | 32 (58) |
| Mismatched related | 2 (4) |
| Matched unrelated | 14 (25) |
| Mismatched unrelated | 7 (13) |
| Conditioning, no. (%) | |
| Standard | 16 (29) |
| Reduced-intensity | 39 (71) |
| Source, PBSC/BM, no. (%) | 54/1 (98/2) |
| Characteristic . | Patients . |
|---|---|
| Sex, male/female, no. (%) | 32/23 (58/42) |
| Age at SCT, y, median (range) | 44 (17-66) |
| Diagnoses, no | |
| ALL | 3 |
| AML | 11 |
| CIMF | 1 |
| CML | 2 |
| MDS | 5 |
| B-CLL | 1 |
| NHL | 9 |
| HD | 1 |
| MM | 21 |
| PNH | 1 |
| Donor, no. (%) | |
| Matched related | 32 (58) |
| Mismatched related | 2 (4) |
| Matched unrelated | 14 (25) |
| Mismatched unrelated | 7 (13) |
| Conditioning, no. (%) | |
| Standard | 16 (29) |
| Reduced-intensity | 39 (71) |
| Source, PBSC/BM, no. (%) | 54/1 (98/2) |
Summary of 55 patients with and without GVHD recruited for longitudinal CK18F measurement (for details see Table S1).
ALL indicates acute lymphoblastic leukemia; AML, acute myeloid leukemia; CIMF, chronic idiopathic myelofibrosis; CML, chronic myeloid leukemia; MDS, myelodysplastic syndrome; NHL, non-Hodgkin lymphoma; HD, Hodgkin disease; MM, multiple myeloma; PNH, paroxysmal nocturnal hemoglobinurea; PBSC, peripheral blood stem cell; and BM, bone marrow.